The single exit price for medicines will rise 2.88% from October. The industry warns rising input costs are straining medicine supply. The single exit price (SEP) of medicines and scheduled substances will rise 2.88% from 1 October. This is the second adjustment this year. South Africa’s pharmaceutical industry warns that rising input costs are squeezing medicine supply and triggering shortages.…
Tag: medicine supply
-
Pharmaceutical Localisation Talks Target Investment And Supply
Senior government officials and top leaders of the pharmaceutical industry have agreed to pursue closer cooperation. South Africa seeks to boost local medicine production and enhance supply security. On 18 August, the two parties met in Pretoria to talk about the immediate pressures facing the sector. They discussed the longer-term measures needed to support pharmaceutical manufacturing. Professor Nicholas Crisp, who…
-
Calls for Drug Company Nationalisation After Adcock Job Cuts
Calls for drug company nationalisation have been made by the General Industries Workers Union of South Africa (Giwusa). These calls follow plans by Adcock Ingram to retrench more than 240 workers. Giwusa president Mametlwe Sebei said South Africa’s pharmaceutical sector had lost about 2,500 direct jobs over the past 18 months. He noted that nine local manufacturing plants closed during…
-
Pharmaceutical industry fights to shield drugs from tariffs
Pharmaceutical giants are actively lobbying the Trump administration and European Union officials to exclude medical goods from escalating trade disputes. They fear significant price increases and restricted patient access to essential medications. The industry’s concerns centre on the potential impact of tariffs on top-selling drugs like Novo Nordisk’s Wegovy for weight loss and Merck’s cancer immunotherapy Keytruda. In discussions with…